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 A multi-component nanosystem based on graphene and comprising individual 
cyclodextrins at its surface is assembled, creating hybrid structures enabling new 
and important functionalities: optical imaging, drug storage, and cell targeting for 
medical diagnosis and treatment. These nanohybrids are part of a universal system 
of interchangeable units, capable of mutilple functionalities. The surface components, 
made of individual  β -cyclodextrin molecules, are the “hosts” for functional units, which 
may be used as imaging agents, for anti-cancer drug delivery, and as tumor-specifi c 
ligands. Specifi cally, individual  β -cyclodextrin ( β -CD), with a known capability to 
host various molecules, is considered a module unit that is assembled onto graphene 
nanosheet (GNS). The cyclodextrin-functionalized graphene nanosheet (GNS/ β -CD) 
enables “host–guest” chemistry between the nanohybrid and functional “payloads”. The 
structure, composition, and morphology of the graphene nanosheet hybrid have been 
investigated. The nanohybrid, GNS/ β -CD, is highly dispersive in various physiological 
solutions, refl ecting the high biostability of cyclodextrin. Regarding the host capability, 
the nanohybrid is fully capable of selectively accommodating various biological and 
functional agents in a controlled fashion, including the antivirus drug amantadine, 
fl uorescent dye [5(6)-carboxyfl uorescein], and Arg-Gly-Asp (RGD) peptide-targeting 
ligands assisted by an adamantine linker. The loading ratio of 5(6)-carboxyfl uorescein 
is as high as 110% with a drug concentration of 0.45 mg mL  − 1 . The cyclic RGD-
functionalized nanohybrid exhibits remarkable targeting for HeLa cells. 
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 For biomedical applications, a nanocarrier is typically devel-
oped with a variety of functional groups for conjugation 
with biological molecules including DNA, RNA, antibodies, 
and other species that are needed in diagnosis and therapy. 
However, this current approach is often complicated, and the 
synthesis and processing remain a challenge due to structural 
and chemical incompatibilities among the nanocarriers, func-
tional groups, and biological molecules. As an example, the 
integration of individual components can lead to by-products 
of aggregated chemical species. [ 1 , 2 ] The multifunctionalities 
required for medical diagnosis and treatment cannot be easily 
and reproducibly assembled into a compact nanosystem. 
These components include a biocompatible nanocarrier 
of a preferred geometry, on which the anti-tumor drug can erlag GmbH & Co. KGaA, Weinheim small 2013, 9, No. 3, 446–456
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fl uorescent dye having an emission, preferably in the near-
infrared range, is needed for in vitro or in vivo imaging. For 
cancer cell targeting, the nanocarrier has to be functionalized 
with a tumor specifi c ligand. However, the assembly of these 
basic components is also complicated by drastically different 
intrinsic behaviors of the nanocarriers. For medical applica-
tions, lacking of consistency and reproducibility in these mul-
tifunctional carriers will present a major barrier to future 
clinical applications. Therefore, these nanocarriers must be 
developed with controlled overall sizes, component ratios, 
and biophysical properties. It is also particularly important 
for the carriers to exhibit controlled drug release and other 
therapeutic effects such as magnetic hyperthermia. 
 The current challenges in the development of multi-func-
tional systems have been that the conventional nanocarriers 
are often limited by their intrinsic structural, physical, and 
chemical complexities. In this study, a versatile nanosystem 
with multifunctionalities was developed with graphene as uni-
versal platform, on which cyclodextrins (CDs) were anchored 
with multiple accommodating sites for various functional units. 
 Graphene is used to develop the nanocarrier system for 
medical imaging, drug delivery, and cell targeting. Graphene 
nanosheet (GNS), a single layer of carbon atoms in a two 
dimensional, close-packed, planar honeycomb structure, is 
a structurally well-defi ned system, which has been utilized 
for biomedical applications, such as biosensors, [ 3 , 4 ] drug 
delivery, [ 5–8 ] imaging etc. [ 4 , 9–11 ] The unique characteristics of 
GNS includes extraordinary electrochemical properties, non-
covalent interaction with many aromatic pharmaceuticals, and 
a super-high surface area. In most of the biomedical applica-
tions, GNS has to be surface functionalized for its manipula-
tion in biological solutions, as strong  π – π interactions between 
individual GNS easily result in irreversible agglomerates or 
even the formation of graphite. [ 12 ] Its oxide derivative, rich 
in carboxyl, hydroxyl and epoxy groups, enables GNS to be 
highly dispersible in pure water. However, the properties of 
the oxide formulation are often compromised by the partially 
destroyed planar structure in the oxidation process. Further-
more, it suffers from instability in biological solutions such 
as culture medium and serum, which is reported to be asso-
ciated with the screening effect of the electrostatic charges 
and nonspecifi c binding of proteins. These complications and 
shortcomings have severely limited graphene applications in 
biomedical diagnosis and treatment. 
 Thus, we propose a new system that provides multiple 
functionalities while maintaining its high structural integrity 
and dispersity. PEG functionalization has been a very useful 
approach for modifying nano-graphene oxide with fragmen-
tary  π − π structure. [ 13–15 ] Pluronic F127-, [ 16 ] chitosan-, [ 17 ] and 
dextran- [ 18 ] functionalized graphene oxide have also been 
recently reported. These methods have effectively improved 
the biological dispersity and biocompatibility of graphene. 
However, the graphene structure remains disordered in the 
carbon skeleton due to a random arrangement of oxygen 
functional groups, which may pose negative effects on its 
electrochemical properties, [ 19 , 20 ] as well as their drug loading 
capability. [ 21 ] On the other hand, drug release and cell inter-
nalization of the nanohybrid can be limited by the use of © 2013 Wiley-VCH Verlag Gmbsmall 2013, 9, No. 3, 446–456surface coated polymers. A PEG selective detachment mech-
anism was recently developed that could effectively release 
drugs in a tumor specifi c environment. [ 22 ] 
 In consideration of these GNS structural characteris-
tics for biomedical requirements, a versatile nano-assembly 
is designed and developed in this study. The system is engi-
neered on a nanoscaled GNS platform  via host–guest 
chemistry between the hybrid and functional payloads. Cyclo-
dextrin (CD), an oligosaccharide consisting of six, seven or 
eight glucose units ( α ,  β , or  γ -CD, respectively), is utilized 
as the “host” molecule. This cone-shaped cavity of CDs can 
serve as hosts for a great variety of functional or biological 
“guest” molecules by taking advantage of its geometric com-
patibility and hydrophobic interactions between the CDs and 
the guest molecules. [ 23 , 24 ] As such, CDs have been widely 
used in biomedical applications, such as drug formulations, 
tissue engineering, and gene/drug delivery. [ 25 ] 
 In this design, as shown in  Scheme  1 , multiple CDs are 
anchored onto GNS in a “one pot” reduction process of 
nano-graphene oxide in the presence of ammonia, resulting 
in a GNS/CD nanohybrid. The GNS/CD nanohybrid, with 
relative integrated  π − π structure and biological dispersity, is 
capable of hosting multiple functional and biological guests. 
Each CD may be regarded as an individual module that ena-
bles the “host–guest” mechanism to accommodate various 
functional units for biomedical applications. 
 A wet-chemical strategy was adopted for the GNS/CDs 
nanohybrid preparation in this study. The experimental results 
indicate that the nanohybrid is highly stable in biological envi-
ronment and fully capable of selectively accommodating var-
ious biological and functional agents, including antivirus drug 
amantadine, fl uorescent dye (5(6)-carboxyfl uorescein), and 
the Arg-Gly-Asp (RGD) peptide-targeting ligands assisted 
with an adamantine linker, which are critical to tumor diag-
nosis and therapy. The controlled release capability of the 
bio-agents can be regulated by adding competitive guest 
molecules via the reversibility of host–guest interaction. [ 26 ] 
 2. Results and Discussion 
 2.1. Preparation and Characterization of the GNS/ β -CD Hybrid 
 Generally, the reduction of graphene oxide proceeds in the 
presence of weak alkaline condition. [ 27 ] Herein,  β -CD, as a 
model host molecule, was assembled onto GNS within the 
process of graphene oxide (GO) reduction in the presence of 
ammonia aqueous solution, affording the graphene nanosheets 
(GNS/CD). The whole process avoids the utilization of toxic 
reduction agent, such as hydrazine or its derivates. In order to 
demonstrate the functionality of  β -cyclodextrin in the process 
of reduction, a controlled experiment was carried out for GO 
reduction without ammonia, or  β -CD, or both under otherwise 
identical conditions. The GO solution changed from brown to 
black in concomitance with the rapid precipitation of conge-
ries occurring in the presence of only ammonia, which mainly 
ascribed to reduced oxygen containing groups resulting in the 
low dispersion capacity for GNS in aqueous phase. The X-ray 
photoelectron spectroscopy (XPS) results show a higher C/O 447www.small-journal.comH & Co. KGaA, Weinheim
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 Scheme  1 .  Schematic illustration for GNS/CD formation and “host and guest” functionalization. GNS/CD nanohybrid, surface capped with large 
quantities of cavities (cyclodextrins), can be used to “host” various functional guests including antivirus drug amantadine, or RGD targeting ligands 
assisted by an adamantine linker. 
 Figure  1 .  Raman spectra of GNS obtained from (a) GO with NH 3 · H 2 O; 
(b) GO with  β -CD and NH 3 · H 2 O; (c) GO with  β -CD; (d) GO only at the 
same reaction conditions of 80  ° C; (e) fl ake graphite. Using Raman 
spectrometer (Renishaw inVia Refl ex, UK) with argon ion laser emitting 
at 514.5 nm (20 mW). molar ratio (2.6) for GNS than that for GO (2.2) (see Figure S1), 
indicating successful reduction. GNS obtained in ammonia 
aqueous solution with  β -CD exhibits good dispersion in water 
for a prolonged time without sinking, suggesting the stabi-
lizing role of  β -CD. Zeta potential shows a strong correlation 
with the oxidation level, as indicated by the functional groups, 
such as COOH, mainly located at the edges of the graphene 
oxide sheets. Weak negative charges are developed in the 
solution due to COOH deprotonation. Zeta potentials of col-
loid GO and GNS/ β -CD are  − 24 mV and  − 19 mV, respectively 
at the same concentration of 35 mg L  − 1 with comparable size. 
These are clear evidences of reduction. In contrast, no obvious 
reduction was found in the controlled experiment with the 
absence of both  β -CD and ammonia. 
 Raman spectroscopy was employed to characterize the 
structural changes during the chemical processes from graphite 
to GO and GNS. The typical features in the Raman spectra 
of fl ake graphite display a prominent G band at 1581 cm  − 1 
and an extremely weak D band at 1352 cm  − 1 , while GO and 
GNS/ β -CD both show pronounced G band around 1594 cm  − 1 
and the D band at 1352 cm  − 1 ( Figure  1 ). The G band is usually www.small-journal.com © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim small 2013, 9, No. 3, 446–456
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 Figure  2 .  (I) UV-vis absorption spectra of GO dispersion (c) and after reduction with ammonia 
and  β -cyclodextrin at 80  ° C for 2 h (a) and 1 h (b), respectively. (II) Size of GO (a); GNS/ β -CD 
(b) and GNS/ β -CD stored at room temperature for one month (c) and three months (d). Inset 
shows the color change of 0.05 mg mL  − 1 GO solution before and after reduction. 
 Figure  3 .  FTIR spectra of GNS/ β -CD (a), GO (b), and  β -CD (c) collected 
using a Tensor 27 FTIR spectrometer. arisen from the E 2g phonon of sp 
2 atoms, and the D band is 
a breathing mode of k-point phonons of A 1g symmetry. The 
intensity ratio (I D /I G ) of D band to G band in graphitic mate-
rials has been used to determine the size of sp 2 domains. [ 28 ] 
The I D /I G ratios for GO and GNS are respectively 0.82 and 
1.0, obtained from GO with ammonia or  β -CD and ammonia. 
The ratio increase, as reported by Ruoff, indicates the decrease 
in size of sp 2 domains, [ 29 ] resulting from the increased number 
of smaller nascent sp 2 domains during reduction process. [ 30 ] 
In contrast to GO reduction in the presence of only  β -CD, the 
slightly increased I D /I G ratio (0.89) also suggests a decrease 
in size of sp2 domains. However, the extent of decrease is not 
as high as in the presence of ammonia based on the compar-
ison of the intensity ratio of characteristic D to G band in the 
Raman spectra (Figure  1 ). This indicates the involvement of 
CD in the reduction process. 
 UV-vis spectroscopy was used to monitor the reduction 
process of GO to GNS as a function of time. To this end, 
1 mL of reactant dispersion was removed from the reaction 
vial every 1 h and their UV-vis spectrum was recorded. As 
shown in  Figure  2 I, the typical UV-vis absorption peak of GO 
dispersion appears at 230 nm, which is due to the  π – π  ∗  tran-
sition of aromatic CC bonds. After reduction in the pres-
ence of ammonia and  β -CD, the maximum absorption peak 
gradually red-shifts to 256 nm and the absorption increases 
in the entire spectral region for prolonged reduction. It is 
likely that the oxygen-containing functional groups on GO 
have been removed in the presence of  β -cyclodextrin under 
weak alkaline condition accompanied by the formation of 
new  π -conjugation network of the graphene nanosheets upon 
deoxidation. The evidence of reduction is also demonstrated 
from the color change of the solution before and after reaction. 
The light brown of GO darkens after reduction (Figure  2 II 
inset) with no obvious size change. By dynamic light scat-
tering (DLS) monitoring, it is found that most of GO in 
aqueous solution is around 120 nm with a small population 
on the order of  ∼ 20 nm. After reduction in the presence of 
 β -CD and ammonia for 2 h, the size is maintained at  ∼ 120 nm 
with no obvious change. Particularly, the as-prepared 
graphene dispersion show long-term stability in water, and 
no pronounced aggregation or precipitation is observed after 
more than one month of storage at room temperature, as © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheimsmall 2013, 9, No. 3, 446–456determined by DLS monitoring shown in 
Figure  2 II. 
 The removal of oxygen-containing 
functional groups on the GO surface 
through  β -CD reduction is also con-
fi rmed by FTIR spectroscopy. The FTIR 
spectra of GO ( Figure  3 ) show a strong 
and broad absorption peak at 3403 cm  − 1 
corresponding to the stretching vibration 
of O–H, and a peak at 1605 cm  − 1 due to 
O–H bending vibration. A diagnostic 
signal at 1730 cm  − 1 for CO stretching 
vibration of COOH is observed. Mean-
while, the absorption peaks of the epoxide 
groups and skeletal ring vibrations are 
situated at 1060 cm  − 1 and 1617 cm  − 1 , 
respectively. For GNS/ β -CD in Figure  3 a, 
the signal of CO at 1730 cm  − 1 is absent, suggesting that 
GO has been reduced to graphene nanosheets. 
The new absorption peak at around 2918 cm  − 1 is mainly 
attributed to the stretching vibration of C–H as well as the 
typical CD absorption fi ngerprint peaks in the range of 
500 ∼ 1100 cm  − 1 (Figure  3 c), confi rming the attachment of CD 
on GNS. 
 1 HNMR data disclose the structural alterations of  β -CD 
before and after reduction process, where the characteristic 
peaks of  β -CD are assigned in the  Figure  4 . A decreased inte-
grated area for hydroxyl groups (OH-2, OH-3, OH-6) of CDs 
in GNS/ β -CD, in comparison with pure  β -CD, is observed 
(Figure  4 a,b). This suggests that the portion of primary and 
secondary hydroxyl groups of  β -CD have been converted to 
other groups like aldedydes/carboxyl groups and ketones, 
respectively as reported. [ 27 , 31 , 32 ] Carboxyl groups are less 
likely, since aldedydes or ketones may further react with 
hydroxyl groups on graphene oxide resulting in formation of 
hemiacetal or acetal, which affords the GNS/ β -CD formation. 
Two facts support this assumption: i) CO stretching band is 
hardly be detected in the FTIR spectra of GNS/ β -CD indi-
cating the insignifi cant role of the involvement of carboxyl 449www.small-journal.com
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 Figure  4 .  1 H NMR spectra of  β -CD (a), freeze-dried GNS/ β -CD (b), freeze-
dried GNS/ β -CD/Ad-NH 2 with increasing loading ratio of Ad-NH 2 [(c) 
3.88 wt%, (d) 5.71 wt%] and Ad-NH 2 (e). (DMSO- d6 as solvent, “Ia” 
denotes integrated area) 
 Figure  5 .  XRD patterns of  β -CD (a), GNS/ β -CD (b), GO (c), and graphite 
(d). CuK α (40 kV, 100 mA) as radiation source with a scanning rate of 
4 ° min  − 1 at 20  ° C. groups, and ii) GNS/ β -CD exposed to acid environment expe-
riences fast aggregation in few minutes. This behavior is asso-
ciated with decomposition of GNS/ β -CD by acid cleavable 
hemiacetal or acetal, leading to hydrophobic GNS precipita-
tion. However, the exact products generated in this process 
are yet to be identifi ed due to the complicated chemical envi-0
 Figure  6 .  The C1s XPS spectra of GO (a), GNS/ β -CD (b), and GNS only (c) are obtained by 
means of a RBD upgraded PHI-5000C ESCA system with A1K α radiation (h ν  = 1486.6 eV). ronment in this unique composite system. 
 Figure 5 shows the X-ray diffraction 
(XRD) patterns of  β -CD, pristine graphite, 
GO, and GNS/ β -CD. XRD pattern of GO 
(Figure  5 c) shows a single sharp diffrac-
tion peak at 2 θ  = 9.34 ° corresponding to an 
interlayer distance of 0.83 nm. This value is 
larger than the interlay spacing of pristine 
graphite, which is 0.34 nm at 2 θ  = 26.5 ° 
(Figure  5 d). This can be ascribed to the 
presence of oxygen-containing functional 
groups, as well as the water molecules held 
in these groups. [ 33 ] In contrast, the diffrac-
tion peak of GNS/ β -CD hybrid (Figure  5 b) 
does not show any residual at 2 θ  = 
9.34 ° after chemical reduction. At 
the same time, a strong broad peak is 
observed at approximately 2 θ  = 23.3 ° 
with an interlayer distance of 0.34 nm. 
These results indicate the removal of the 
oxygen-containing functional groups and 
the reduction of GO. The XRD pattern of 
GNS/ β -CD also shows the similar charac-
teristics of  β -CD (Figure  5 a), indicating the 
presence of  β -CD on the surface of GNS. 
 X-ray photoelectron spectros-
copy (XPS) was completed in order 
to further confi rm the removal of the www.small-journal.com © 2013 Wiley-VCH Veoxygen-containing functional groups. C 1s XPS results ( Figure 6 ) 
show that four components are found to be associated with 
carbon atoms in the C 1s region. The peak located at 284.5 eV 
is attributed to the sp 2 carbon components, and C 1s of C–O, 
CO, and O–CO are observed at 286.6 ev, 287.8 eV and 
288.9 eV, respectively. For the GNS/ β -CD hybrid (Figure  6 b), 
the peak intensities corresponding to CO and O–CO are 
much lower than that of GO, indicating effective reduction 
of GO. The C–O peak intensity increases mainly due to the 
presence of  β -CD, which is confi rmed by the lower intensity rlag GmbH & Co. KGaA, Weinheim small 2013, 9, No. 3, 446–456
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 Figure  7 .  TGA curves of fl ake graphite (a), GO (b), GNS/ β -CD hybrid (c), 
and  β -CD (d) obtained under a nitrogen fl ow of 100 mL min  − 1 with the 
heating rate of 5  ° C min  − 1 . of C–O peak for GNS only (Figure  6 c). The above results fur-
ther indicate successful reduction of GO. 
 The content of  β -CD in GNS/ β -CD hybrid was deter-
mined by thermogravimetric analysis (TGA). The component 
of fl ake graphite, GO, as well as  β -CD as the control, were 
also analyzed. As is well known, GO is thermally unstable 
with steps of mass loss at elevated temperatures. As shown 
in  Figure  7 b, there is a slight weight loss below 100  o C, due 
to evaporation of water, and about 45% mass loss around © 2013 Wiley-VCH Verlag Gmb
 Figure  8 .  Photos of GO (a), GNS/ β -CD (b) in different medium and atom
tapping mode (d). 
small 2013, 9, No. 3, 446–456180 ∼ 400  ° C, presumably attributed to the pyrolysis of the 
thermally-labile, oxygen-containing functional groups. [ 34 ] The 
mass loss above 400  ° C is attributed to the bulk pyrolysis of 
carbon skeleton, which is similar to graphite Figure  7 a. In con-
trast, the removal of the thermally labile oxygen functional 
groups via chemical reduction enhances the thermal stability 
of graphene nanosheet. As shown in Figure  7 c, only insignifi -
cant mass loss was observed around 200  ° C due to the small 
quantity of residual oxygen-containing groups, suggesting the 
removal of most of the oxygen-containing functional groups. 
The pronounced mass loss in the range from 250  ° C to 
350  ° C is linked to thermal decomposition of  β -CD, which 
is consistent with pure  β -CD (Figure  7 d). The amount of 
 β -CD is determined to be 63% (about one CD per 55 carbon 
atoms), indicating that a large amount of CD molecules has 
been anchored on GNS. As shown in  Figure  8 c, the average 
thickness of GO is 0.876 nm, which is on the order of two 
layers of graphene, and the lateral size is around 80 nm. In 
contrast, the average thickness of GNS/ β -CD (Figure  8 d) is 
11.42 nm, much thicker than that of GO, suggesting abundant 
 β -CD anchored on the surface of GNS. Aggregation of GNS 
is possible before  β -CD attachment to afford GNS/ β -CD. 
 2.2. Stability, Cytotoxicity, and Hemolysis Assay of the 
GNS/ β -CD Hybrid 
 For biomedical applications, good dispersion in a physiolog-
ical medium is a prerequisite. These studies were completed 
on the colloidal stabilities of GO and GNS/ β -CD hybrid in 451www.small-journal.comH & Co. KGaA, Weinheim
ic force microscope (AFM) images of GO (c) and GNS/ β -CD obtained in 
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 Figure  9 .  Effects of GNS/ β -CD concentration and incubation time on 
morphological changes of human erythrocytes. Exposures to PBS for 
1 h (a) and 4 h (b); exposures to GNS/ β -CD suspension 10 mg L  − 1 for 
1 h (c) and 4 h (d); exposures to GNS/ β -CD suspension 40 mg L  − 1 for 
1 h (e) and 4 h (f). different media including water, phosphate buffered saline 
(PBS), serum and Dulbecco’s modifi ed Eagle’s medium 
(DMEM). GO is steadily dispersed in water but aggregated 
in aqueous solutions that are rich in salts or proteins, such 
as serum and DMEM (Figure  8 ). This is probably due to 
screening of the electrostatic charges and non-specifi c binding 
of proteins on GO. [ 35 ] In contrast, GNS/ β -CD hybrid exhibits 
excellent stability in all biological solutions for more than one 
month, showing its great potential in biomedical applications. 
 Cytotoxicity of GNS/ β -CD hybrid was investigated 
in vitro. HeLa cells were chosen as model cell lines. The 
experimental results of WST assay show low potent cancer 
cell killing for GNS/ β -CD in vitro with HeLa cells. The cell 
viability is more than 80% even at a high concentration of 
200 mg L  − 1 , indicating low cytotoxicity of GNS/ β -CD. 
 In vitro hemolysis assay of healthy human red blood cor-
puscles was also carried out.  Figure  9 shows optical micro-
scopy analysis of erythrocyte morphology after incubation 
with pure PBS and GNS/ β -CD suspension of different con-
centrations (10 and 40 mg L  − 1 ). It is found that nearly all the 
erythrocyte membranes are kept integrated when incubated 
with PBS for up to 4 h (Figure  9 a,b). Even with erythrocyte 
surface attached GNS/ β -CD, the suspension shows little 
effect on the erythrocyte morphology and membrane integ-
rity at the dosage of 10 and 40 mg L  − 1 for 1 h (Figure  9 c,e). 
However, erythrocyte membranes experience partial rupture 
when exposed to 10 and 40 mg L  − 1 for 4 h (Figure  9 d,f). In line 
with this, surface membrane of erythrocytes is progressively 
compromised by GNS/ β -CD in a dose (5, 10, 40 mg L  − 1 )-
dependent manner. This behavior has lead to the release of 
free hemoglobin in the medium as evidenced from the UV 
absorption intensity of hemoglobin at 541 nm. The hemo-
lysis percentages of GNS/ β -CD are respectively 20%, 32%, 
and 49% for the dosage of 5, 10, and 40 mg L  − 1 GNS/ β -CD 
for 4 h. Compared with percent hemolysis of GNS reported 
( < 10% at 40 mg L  − 1 dose for 3 h), [ 36 ] the presence of  β -CD 
is the main cause leading to hemolysis. [ 37 ] Other factors such 
as nanomaterials size, incubation time with erythrocytes, and 
surface charge [ 36 ] should also be taken into consideration.  Figure  10 .  (a) Fluorescence spectra of FAM and FAM loaded GNS/CD in water at 492 nm 
excitation wavelength. Signifi cant fl uorescence quenching is observed for FAM loaded GNS/
CD. (b) The loading ratio of 5,6-FAM on GNS/ β -CD at different concentrations. Inset is the 
photos for FAM, GNS/ β -CD and FAM loaded GNS/ β -CD aqueous solution.  2.3. Drug Loading Capacity 
 The payload capacity of GNS/ β -CD 
was investigated. 5,6-carboxyfl uorescein 
(5,6-FAM) was used as a model cargo for 
its fl uorescence and potent interaction 
with GNS via  π – π stacking. The aqueous 
solution color change was observed from 
yellow (for FAM only) to dark green (for 
FAM loaded GNS/ β -CD dialysis solution; 
 Figure  10 b inset). The loading process 
resulted in a fl uorescence quenching of 
FAM (Figure  10 a) due to a photo-induced 
electron-transfer effect. [ 22 ] The loading 
capacity was studied for GNS with various 
concentrations of 5,6-FAM. The loading 
capacity gradually improved at higher 
concentrations. As shown in Figure  10 b, www.small-journal.com © 2013 Wiley-VCH Vthe drug loading ratio can be as high as 110% at the con-
centration of 0.45 mg mL  − 1 . The  π – π stacking between 
5,6-FAM and GNS is believed to be the major driving force 
for absorption. Comparing with 178% loading ratio of GO 
for FAM at the same concentration, the lower drug loading 
ratio of GNS/ β -CD is likely attributed to the reduced surface 
area resulting from the thicker GNS/ β -CD sheets. 
 CDs are an ideal candidate for developing nanosystem 
platform with multiple anchoring sites. Their cone shaped 
cavity can act as hosts for a wide variety of functional and 
biological guest molecules to form host–guest inclusion com-
plexes, driven by geometric compatibility and hydrophobic 
interactions. Ad-NH 2 , an anti-virus drug, was chosen as a model erlag GmbH & Co. KGaA, Weinheim small 2013, 9, No. 3, 446–456
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 Figure  11 .  Size change of GNS/ β -CD (0.2 mg mL  − 1 ) upon addition of 
different amounts of Ad-NH 2 . drug to investigate the loading capability of GNS/ β -CD hybrid 
 via host–guest interaction. The storage of Ad-NH 2 within the 
hybrid was confi rmed by size change of GNS/ β -CD upon addi-
tion of Ad-NH 2 . As shown in  Figure  11 , the size of GNS/ β -CD 
gradually increases by adding Ad-NH 2 . This behavior is associ-
ated with the inclusion of Ad-NH 2 in the  β -CD cone. 
 1 H NMR experiment was employed to further investigate 
the inclusion complex of Ad-NH 2 and  β -CD, as the proton 
environments of both host and guest usually change upon 
binding. The internal H-3 and H-5 protons in  β -CD are more 
sensitive to complexation than those outside the host cavity 
(H-1, H-2, and H-4). [ 26 ] As shown in Figure  4 , an upfi eld 
shift of H-5 signals of  β -CD and the downfi eld shift for char-
acteristic signals of Ad-NH 2 locating at approx. 2 ppm are 
observed after the loading process. The peak shape change  Figure  12 .  Representative confocal laser scanning micrographs of cellular uptake of FAM 
loaded GNS/ β -CD/Ad-RGD for HeLa cells preincubation with (a 1 ) or without (b 1 ) RGD-AD for 
2 h followed by another 8 h incubation, (c 1 ) cellular uptake of FAM loaded GNS/ β -CD 
(excitation wavelength: 488 nm). is also observed for Ad-NH 2 in the range 
of 0.8–1.2 ppm, as shown in Figure  4 c,d. In 
addition, the intensifi ed signals for Ad-NH 2 
are detected with the increased dosage 
of Ad-NH 2 , as described in the experi-
mental section. The weight loading ratio 
of Ad-NH 2 is calculated to be 3.88% and 
5.71%, respectively, which are close to the 
Ad-NH 2 feed ratio (4.0 wt%, 6.67 wt%). 
 2.4. Cell Targeting Study 
 For active targeting effect using the “host–
guest” strategy, cyclic RGD conjugated 
Ad (Ad-RGD) was used as the targeting 
moiety and surface-functionalized onto 
the GNS/ β -CD hybrid. The cyclic RGD 
peptide selectively recognizes  α v β 3 and 
 α v β 5 integrin receptors, which plays a piv-
otal role in angiogenesis, vascular intima 
thickening, and proliferation of malignant 
tumors. [ 38 ] HeLa cells possessing  α v β 3 
and  α v β 5 integrins were chosen as model © 2013 Wiley-VCH Verlag Gmsmall 2013, 9, No. 3, 446–456cell lines to investigate the targeting effect. The endocytosis 
experiments with and without RGD shielding was completed 
in order to investigate the targeting effect of Ad-RGD loaded 
GNS/ β -CD (GNS/ β -CD/Ad-RGD) on HeLa cells. Since the 
fl uorescence of GNS is barely detectable, FAM was loaded 
onto GNS/ β -CD for fl uorescence signal detection. From the 
images of confocal laser scanning microscopy (CLSM) shown 
in  Figure  12 , there is a sharp contrast in fl uorescent signals 
between GNS/ β -CD/Ad-RGD (strong) and GNS/ β -CD 
(weak). The green signals are the weakest in cells pre-incu-
bated with free RGD-Ad followed by further incubation 
with FAM-loaded GNS/ β -CD/Ad-RGD. These experimental 
results indicate the interactions between the free RGD-Ad 
and the integrin receptors. However, interactions of receptors 
with RGD-Ad loaded FAM/GNS/ β -CD are strongly ham-
pered, leading to a lower uptake of FAM-loaded GNS/ β -CD/
Ad-RGD via integrin-mediated endocytosis. Consistent with 
the results of fl ow cytometric analysis (FCA), there is sig-
nifi cant FAM fl uorescence difference between HeLa cells 
treated with FAM-loaded GNS/ β -CD/Ad-RGD and the con-
trol experiments. This is a clear evidence of strong targeting 
effect due to RGD-Ad loaded GNS/ β -CD ( Figure  13 ). 
 Importantly, several other different functional moieties 
can also be loaded onto this carrier system. For example, the 
anticancer drug Dox-Ad and polyarginine-Ad with trans-
membrane capability can be easily loaded onto the template 
at the same time. Furthermore, our previous work has shown 
the controlled release of bio-agents, which is regulated by 
adding competitive guest molecules,  via the reversibility of 
host–guest interaction. [ 26 ] 
 3. Conclusion 
 In summary, a unique GNS/ β -CD system has been developed 
from exfoliated GO and  β -cyclodextrin. The versatile system 453www.small-journal.combH & Co. KGaA, Weinheim
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 Figure  13 .  Flow cytometric analysis of HeLa cells nontreated (1) and 
treated by GNS/ β -CD (2), FAM loaded GNS/ β -CD/Ad-RGD (3), FAM 
loaded GNS/ β -CD (4) and free Ad-RGD pretreated HeLa cells incubated 
with GNS/ β -CD/Ad-RGD (5). combines the advantages of graphene and cyclodextrins that 
provide multifunctional and inter-reversible anchor sites. The 
hybrid is found to possess a high drug-loading capacity and 
strong targeting effect. These functionalities are easily assem-
bled, in a reproducible and controlled fashion. The hybrid can 
serve as a basic unit for the assembling of a variety of complex 
system depending upon the specifi c biomedical requirements. 
The model hybrid tested in this investigation has demonstrated a 
high drug loading effi ciency and strong cell targeting capability. 
 4. Experimental Section 
 Chemicals : Flake graphite was purchased from Shanghai Yifan 
Graphite Co., Ltd., with an average particle diameter of 25  μ m 
(purity  > 99.9%). H 2 SO 4 (AR, 98%), H 2 O 2 (AR, 30%), NaNO 3 (AR), 
KmnO 4 (AR), and NH 3 · H 2 O (25%) were obtained from Sinopharm 
Chemical Reagent Co. Ltd. The drug model 5(6)-carboxyfl uores-
cein (5(6)-FAM) and  β -cyclodextrin ( β -CD) were purchased from 
Aladdin Chemistry. Co. Ltd. Amantadine (Ad-NH 2 ) was obtained 
from Ad-NH 2 · HCl by removing HCl under alkaline solution followed 
by repeated precipitation and extraction process. c(RGDfk)-Ad was 
purchased from GL Biochem, Ltd. (Shanghai). 
 Characterization : Fourier transform infrared (FTIR) spectra 
were collected using a Tensor 27 FTIR spectrometer (Bruker 
AXS, China). UV-vis spectra were recorded on an UV-vis 
spectrophotometer (Varian, Ltd, Hong Kong) with a sample 
concentration of 0.05 mg mL  − 1 .  1 H-Nuclear magnetic reso-
nance ( 1 H NMR) spectra were acquired using the Avance III 
400 MHz spectrometer (Bruker), DMSO- d 6 was used as solvent. 
X-ray diffraction (XRD) were carried out on a D/max2550VB3 + /
PC X-ray diffractometer (Rigaku International Corporation, Japan) 
using CuK α radiation (40 kV, 100 mA) with a scanning rate of 
4 ° min  − 1 at 20  ° C. Raman spectra were collected from 800 cm  − 1 to 
2000 cm  − 1 on a Raman spectrometer (Renishaw inVia Refl ex, UK) 
with argon ion laser emitting at 514.5 nm (20 mW). Atomic force 
microscope (AFM) images were obtained using a Veeco Dimen-
sion 3100 atomic force microscope in the tapping mode for the www.small-journal.com © 2013 Wiley-VCH Vmorphological analyses. Thermogravimetric analysis (TGA) was per-
formed on a STA 449C Jupiter (Netzsch, Germany) under a nitrogen 
fl ow of 100 mL min  − 1 . All samples were heated from room tempera-
ture to 800  ° C at a heating rate of 5  ° C min  − 1 . X-ray photoelectron 
spectroscopy (XPS) was carried out by means of a RBD upgraded 
PHI-5000C ESCA system (RBD Enterprises, USA) with A1K α radia-
tion (h ν  = 1486.6 eV). The size distribution of GNS/ β -CD was 
determined by Zeta Sizer Nano ZS (ZEN 3690, Malvern). The cel-
lular uptake was observed using fl uorescence microscopy (Nikon 
ECLIPSE 80i) and Laser Scanning Confocal Microscope (Leica TCS 
SP5 II, Germany). Flow cytometric analysis was carried out by FACS 
Calibur Flow Cytometer (BD Biosciences, USA). 
 Preparation of GO : Graphene oxide was synthesized according to 
the modifi ed Hummers’ method from fl ake graphite. [ 39 ] The size of GO 
was controlled by adjusting additional amount of oxidation agent and 
oxidation time. [ 14 ] 
 Preparation of GNS/ β -CD Nanohybrid : In a typical process 
for reduction of GO to GNS,  β -cyclodextrin (40 mg) were added 
into homogeneous graphene oxide aqueous suspension (25 mL 
0.1 mg mL  − 1 ), followed by vigorous stirring for 0.5 h under ultra-
sonication (100 W, 40 KHz). Ammonia solution (25% w/w, 20  μ L) 
was subsequently added into the mixture. After being vigorously 
stirred for a few minutes, the mixture was allowed to react for 2 h 
at 80  ° C. The mixture was cooled to room temperature and dia-
lyzed against the deionized water to remove the superfl uous  β -CD 
and ammonia solution. Finally, a black stably dispersed graphene 
aqueous dispersion was obtained. Partial was sampled and freeze-
dried for the following characterizations. 
 Preparation of the Inclusion Complex of GNS/ β -CD with Ad-NH 2 
or Ad-RGD : The inclusion complexation of  β -CD on GNS/ β -CD with 
its matched guest molecule Ad-NH 2 was carried out by mixing the 
GNS/ β -CD (0.2 mg mL  − 1 , 30 mL) with different dosage of Ad-NH 2 
(2 mg mL  − 1 , 120  μ L and 200  μ L respectively) in aqueous solution. 
After shaking for several hours, the mixture was dialysis against 
water exhaustedly followed by freeze-drying and characterized 
by  1 H NMR. The weight loading ratio of Ad-NH 2 was calculated by 
combination of  1 H NMR and TGA data of GNS/ β -CD. The molar ratio 
of  β -CD and Ad-NH 2 can be obtained from the ratio of the inte-
grated area of the characteristic peak (H-1) of  β -CD and the peak 
at 1.50 ∼ 2.01 ppm for Ad-NH 2 . The inclusion complex behavior was 
also monitored by DLS. The size change of GNS/ β -CD was observed 
upon addition of Ad-NH 2 . Ad-NH 2 was added, with gradually 
increasing amount, into GNS/ β -CD aqueous solution (0.2 mg mL  − 1 , 
1 mL) in a cell. The size change was real-time monitored. The 
inclusion complex of  β -CD on GNS/ β -CD with Ad-RGD was carried 
out according above procedure; Ad-RGD (200  μ g) was added to 
GNS/ β -CD aqueous solution (0.2 mg mL  − 1 , 4 mL). The GNS/ β -CD/
Ad-RGD hybrid was obtained by dialysis against the mixture against 
water, followed by centrifugation. 
 Loading of 5,6-FAM onto GNS/ β -CD or GNS/ β -CD-Ad-RGD 
Nanohybrid : The loading of 5,6-FAM was carried out by simply 
mixing GNS/ β -CD or GNS/ β -CD-Ad-RGD with the given amount 
of 5,6-FAM. The loading of FAM onto GO was also carried out as 
a control following the same loading protocol of that GNS/ β -CD. 
In detail, GNS/ β -CD aqueous solution (0.05 mg mL  − 1 , 10 mL) was 
fi rst sonicated with a given concentration of 5,6-FAM for 0.5 h, and 
then stirred for 12 h at room temperature in the dark. The mixture 
was then ultracentrifuged at 13000 rpm for 1 h and the super-
natant was collected. The UV spectrum of the supernatant was erlag GmbH & Co. KGaA, Weinheim small 2013, 9, No. 3, 446–456
Multicomponent Assembly via  β -cyclodextrin Host–Guest Chemistrymeasured at 492 nm and the amount of the unloaded 5,6-FAM was 
estimated according to the standard curve of 5,6-FAM. 
Consequently, the amount of 5,6-FAM loaded onto the hybrid was 
calculated by excluding the unloaded part in supernatant from 
the initial dose. The drug loading ratio was calculated from the 
following formula:
 
Drug loadin ratio (%)




 Cell Lines : The human epitheloid cervix carcinoma (HeLa) cells 
were supplied by Cell Center of Tumor Hospital of Fudan Univer-
sity (Shanghai, China). Cells were propagated in T-75 fl asks under 
an atmo-sphere of 5% CO 2 at 37  ° C and grown in DMEM supple-
mented with fetal bovine serum (10%) and penicillin–streptomycin 
(0.1%). 
 In vitro Cytotoxicity of GNS/ β -CD by WST-1 Assay : Cytotoxicity 
of GNS/ β -CD against HeLa cells was determined by standard WST-1 
assay using WST-1 cell proliferation and cytotoxicity assay kit. In 
brief, HeLa cells were seeded in 96-well plates (5000 cells well  − 1 ) 
using DMEM medium (200  μ L), and incubated at 37  ° C for 24 h. 
The medium in each well was then replaced with culture medium 
containing GNS/ β -CD (150  μ L). The concentration of GNS/ β -CD was 
diluted with culture medium to obtain a concentration range from 
0 to 263 mg L  − 1 . After incubation for 24 h, the medium in each 
well was replaced with fresh medium (100  μ L) and WST-1 solution 
(10  μ L). The plate was incubated for another 4 h at 37  ° C, allowing 
viable cells to reduce WST-1 into the orange formazan. The plate 
was read at 450 nm on a Bio-Rad microplate reader (Thermo Fisher 
Scientifi c, Waltham, MA, USA). 
 The relative cell viability (%) was calculated by the following 
equation: Cell viability  = (OD treated /OD control )  × 100%, where 
OD treated was obtained in the presence of GNS/ β -CD and OD control 
was obtained from the incubation medium. Data are presented as 
average ± SD (n  = 6). 
 Cellular Uptake of GNS/ β -CD/FAM and Targeting Performance: 
To monitor cellular uptake of GNS/ β -CD/FAM as well as the tar-
geting effect of RGD loaded GNS/ β -CD/FAM, HeLa cells (1  × 10 5 
cells well  − 1 ) were incubated with exposure to several different 
groups: i.e. GNS/ β -CD/FAM, and GNS/ β -CD/Ad-RGD/FAM pre-incu-
bated initially with or without free Ad-RGD for 2 h, respectively. 
After incubation at 37  ° C for 8 h, the culture medium was removed 
and cells were rinsed three times with DPBS. Then paraformalde-
hyde (4%) was added and kept at room temperature for 15 min. 
The cells were rinsed twice again with DPBS, and imaged by laser 
scanning confocal microscope (Leica TCS SP5 II, Germany). 
 Cellular uptake of above three types of materials was also 
measured by fl ow cytometric analysis (FACS). Briefl y, HeLa cells 
were seeded in 6-well plate at 1  × 10 5 cells well  − 1 and incubated 
for 24 h. The cells were then incubated at 37  ° C with GNS/ β -CD, 
GNS/ β -CD/FAM, and GNS/ β -CD/Ad-RGD/FAM pre-incubated ini-
tially with or without free Ad-RGD for 2 h, respectively. After incu-
bation for 8 h, cells were washed with DPBS twice and harvested, 
then suspended in paraformaldehyde (2%, 500  μ L) for FACS anal-
yses using FACS Calibur fl ow cytometer (BD Biosciences, USA). 
 Observation of the Erythrocyte Morphology and Erythro-
cyte Hemolysis Assay : In vitro hemolysis assay was carried out 
as described. [ 36 ] Briefl y, fresh EDTA-stabilized human whole 
blood sample was collected from healthy volunteer. Typically, © 2013 Wiley-VCH Verlag Gmbsmall 2013, 9, No. 3, 446–456 [ 1 ]  Y.  Guo ,  D. L.  Shi ,  H. S.  Cho ,  Z. Y.  Dong ,  A.  Kulkarni ,  G. M.  Pauletti , 
 W.  Wang ,  J.  Lian ,  W.  Liu ,  L.  Ren ,  Q. Q.  Zhang ,  G. K.  Liu ,  C.  Huth , 
 L. M.  Wang ,  R. C.  Ewing ,  Adv. Funct. Mater.  2008 ,  18 ,  2489 . 
 [ 2 ]  D. L.  Shi ,  N. M.  Bedford ,  H. S.  Cho ,  Small  2011 ,  7 ,  2549 . 
 [ 3 ]  Y. Y.  Shao ,  J.  Wang ,  H.  Wu ,  J.  Liu ,  I. A.  Aksay ,  Y. H.  Lin ,  Electroanal. 
 2010 ,  22 ,  1027 . 
 [ 4 ]  Y.  Wang ,  Z.  Li ,  J.  Wang ,  J.  Li ,  Y.  Lin ,  Trends Biotechnol.  2011 ,  29 , 
 205 . 
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 [ 6 ]  L. M.  Zhang ,  J. G.  Xia ,  Q. H.  Zhao ,  L. W.  Liu ,  Z. J.  Zhang ,  Small 
 2010 ,  6 ,  537 . 
whole blood (2 mL) was added to PBS (4 mL) and centrifuged at 
4000 rpm for 5 min at 4  ° C (Thermal Fisher Electron Corporation, 
Heraeus Biofuge Strators, Germany) to separate erythrocytes. The 
purifi cation step was repeated four times, and washed erythro-
cytes were fi nally re-suspended to the desired hematocrit level 
using the same buffer and stored at 4  ° C and used within 6 h of 
sample preparation. 
 The effect of GNS/ β -CD on the erythrocyte morphology changes 
was investigated by optical microscopy. Erythrocyte suspension 
(10% hematocrit) was incubated with various doses of GNS/ β -CD 
suspension. At different time intervals, 100  μ L of these incubated 
mixtures were dropped onto glass slide and erythrocyte shape 
changes were observed by optical microscopy directly; the overall 
magnifi cation was 400 × . 
 The in vitro effect of human erythrocyte hemolysis by 
GNS/ β -CD was evaluated according to the procedures described 
elsewhere. [ 40 , 41 ] An erythrocyte suspension (10% hematocrit) was 
exposed to different concentrations of GNS/ β -CD in PBS. In order 
to obtain positive and negative controls, erythrocytes were sus-
pended either in deionized water or PBS, respectively. 
 Samples were incubated in a rocking shaker at 37  ° C for 4 h, a 
volume of 200  μ L of the samples was removed and diluted with PBS 
(3.8 mL) and centrifuged at 4000 rpm for 10 min. The absorbance 
of the resulting supernatant (A) as well as the positive and negative 
controls were measured at 541 nm by a UV-Vis spectrophotometer. 
Percent hemolysis was calculated using the following equation:
 
Percent hemolysis(%)
= Samples Abs 541 nm−Negative control Abs 541 nmPositive control Abs 541 nm−Negative control Abs 541nm
× 100%  
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